NCT02290925 The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study Status COMPLETED Phase PHASE3
NCT02290301 An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin Status COMPLETED Phase N/A
NCT02289612 Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products Status COMPLETED Phase NA
NCT02287285 Determinants of Diabetes Remission After Gastric Bypass Surgery Status COMPLETED Phase EARLY_PHASE1
NCT02285881 Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care. Status COMPLETED Phase NA
NCT02273050 Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control Status COMPLETED Phase PHASE3
NCT02251431 Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome Status COMPLETED Phase PHASE3
NCT02250794 Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit Status WITHDRAWN Phase PHASE4
NCT02250222 Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02248714 The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 Diabetes Status COMPLETED Phase NA
NCT02244879 Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients Status COMPLETED Phase PHASE3
NCT02243176 24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy Status COMPLETED Phase PHASE4
NCT02240420 Diabetes Prevention Among Post-partum Women With History of Gestational Diabetes Status COMPLETED Phase NA
NCT02235519 Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients Status UNKNOWN Phase PHASE2/PHASE3